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• PredicTM:  
To predict the seven TM domains our current approach (PredicTM) combines 
hydrophobicity analysis with information from multiple sequence alignments, involving six 
steps: 
i. Retrieval of similar protein sequences from a database (here we select ~2000 sequences 
with structural identities down to ~ 5%) 
ii. Multiple sequence alignment of sequences using the MAFFT23 multiple sequence 
alignment program with the "E-INS-i" method, iterative refinement options, in which pairwise 
alignment information are incorporated into objective function. We find this to be the best suited 
mode for sequences with multiple aligning segments separated by non-aligning segments, which 
is the situation for GPCRs.  The results for the 4 adenosine receptor subtypes and related 
sequences are shown in Fig. 1. 
iii. Hydrophobic profile generation and noise removal. We calculate the consensus 
hydrophobicity for every residue position in the alignment using the average hydrophobicity of 
all the amino acids in that position over all of the sequences in the multiple sequence alignment 
(using the thermodynamic and biological hydrophobic scales from White and von Heijne24, 25).  
Unresolved amino acids in the alignment (B, Z, J, X) are replaced with gaps. Here we eliminate 
noise by averaging windows of 7 amino acids through 21 amino acids, where 7 corresponds 
roughly to one helical turn above and below a residue and 21 corresponds roughly to the length 
of one TMH region.  The plot for hAA3R is shown in Fig. S1 of Supporting Information. 
iv. Initial TMH region predictions. The initial TMH domain predictions are simply the 
regions with hydrophobicity values greater than zero, resulting in "raw helices."  
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v. Application of capping rules. The raw helices are extended (or capped) on both N- and C- 
termini until a “helix breaker” residue is found. To predict correctly this secondary structure 
outside the membrane, we extend both sides of the predicted hydrophobic regions using 
consensus helices based on the APSSP226 and PORTER27 servers. 
vi. Identification of hydrophobic centers: To place all helices on the same reference plane we 
select the “hydrophobic center” for each helix as the position in the raw helix where the 
geometry hydrophobic center is equal on both sides. The results of these last 3 steps are shown in 





Table S1. The predicted seven transmembranic helix (TMH) regions and hydrophobic centers 
(HPC). The raw helices are extended (or capped) on both N- and C- termini until a “helix 
breaker” residue is found. To predict correctly this secondary structure outside the 
membrane, we extend TM3 and 6 using consensus helices based on the secondary 
structure prediction,  APSSP226 and PORTER27 servers. 
TMH Start Sequence Stop Length HPC 
1 Raw 13     VTYITMEIFIGLCAIVGNVLVICVV 37 25 25.5 
 Cap 9 SLANVTYITMEIFIGLCAIVGNVLVICVVK 38 30 24.0 
2 Raw 47 TFYFIVSLALADIAVGVLVMPLAIVVS 73 27 60.5 
  Cap 47 TFYFIVSLALADIAVGVLVMPLAIVVS 73 27 60.5 
3 raw 81 YSCLFMTCLLLIFTHASIMSLLA 103 23 92.5 
 cap 81 YSCLFMTCLLLIFTHASIMSLLA 103 23 92.5 
 SS 81 YSCLFMTCLLLIFTHASIMSLLAIAVDRYLRVK 113 33 97.5 
4 raw 129    LALGLCWLVSFLVGLTPMF 147 19 138.5 
  cap 126 RIWLALGLCWLVSFLVGLTPMFG 148 23 137.5 
5 raw 177   MVYFSFLTWIFIPLVVMCAIYLDI 200 24 189.0 
 cap 175 DYMVYFSFLTWIFIPLVVMCAIYLDIFYIIR 205 31 190.5 
6 raw 233               FLVLFLFALSWLPLSIINCII 253 21 243.5 
 cap 230            KSLFLVLFLFALSWLPLSIINCII 253 24 242.0 
  SS 219 GAFYGREFKTAKSLFLVLFLFALSWLPLSIINCII 253 35 236.5 
7 raw 265 YMGILLSHANSMMNPIVY 282 18 274.0 
  cap 265 YMGILLSHANSMMNPIVYAYK 285 21 275.5 
 
- HPC: PredicTM raw geometric hydrophobic center 
- cap: capped helix extension  
- SS: helix extension from the secondary structure prediction 
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Table S2. Top 7 ligand conformations of Cl-IB-MECA ordered by mpsim total energy (TotE, 
kcal/mol) from Conformational search. The torsion angles Car-Car-NH-Cal (Tot1) and Car-
NH-Cal-Car (Tot2) between the adenine ring and the benzyl substituent were rotated by 
60 ° increments to generate 36 conformations. We selected the lowest 7 ligand 
conformations in grey shading (within 3 kcal/mol of the best E) for docking. The final 
docked structure with the best binding E is shown in bold face.  
# Tot1 Tot2 TotE 
28 -176.18 -179.45 46.05 
16 173.67 167.24 46.98 
24 179.27 -71.28 48.54 
23 -179.75 -120.64 48.61 
21 -178.25 118.41 48.80 
8 27.11 86.64 49.19 
11 33.21 -107.98 49.22 
7 7.05 63.21 49.25 
22 -179.02 178.75 49.34 
10 17.77 -163.16 49.38 
27 -138.51 119.65 49.60 
13 156.50 -70.48 49.60 
4 -2.49 -176.77 49.87 
19 166.01 -9.84 50.25 
9 36.92 131.94 50.31 
3 -5.19 117.21 50.36 
2 1.13 65.23 50.51 
5 1.66 -111.64 50.57 
20 -175.38 65.27 51.07 
6 -6.04 -59.74 51.30 
30 -144.33 -58.59 51.57 
29 -135.58 -116.71 51.81 
26 -138.88 75.54 52.05 
15 137.01 115.85 52.07 
18 139.81 -80.69 52.20 
17 132.36 -123.60 52.55 
34 -34.86 173.21 52.88 
33 -47.91 114.61 53.43 
25 -152.12 66.02 53.60 
31 -14.38 -56.87 53.84 
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35 -49.86 -123.49 53.87 
36 -40.95 -74.57 54.34 
12 49.29 -64.68 54.59 
1 32.47 1.91 55.44 
14 137.88 59.55 56.52 
32 -67.11 72.99 56.65 
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Table S3. The relative difference of the six degrees of freedom for each helix (x, y, z, θ, φ, η) 
among the x-ray structures of turkey β1 adrenergic (PDB ID: 2vt4) and human adenosine 
A2A receptors (PDB ID: 3eml) compared to human β2 adrenergic receptor (PDB ID: 
2rh1).  
Turkey β1 adrenergic receptor  
TM EtaRes δX δY δHPC δTheta δPhi δEta δSTD 
1 N 59 -0.55 -0.56 0.29 2.70 -3.54 3.41 2.52 
2 D 87 -0.22 0.00 -0.01 1.75 2.56 -6.01 3.01 
3 D 121 0.00 0.00 0.06 0.20 0.94 -1.74 0.88 
4 W 166 0.02 0.07 -0.14 -0.81 4.22 4.92 2.50 
5 P 219 -0.04 0.11 -0.23 0.05 4.34 -0.52 1.84 
6 P 305 -0.31 -0.03 -0.07 0.20 -6.14 -3.84 2.66 
7 P 340 -0.20 -0.14 0.17 -3.36 -0.55 3.35 2.14 
STD 0.20 0.23 0.18 1.93 3.96 4.11 1.77 
Human adenosine A2A receptor       
TM EtaRes δX δY δHPC δTheta δPhi δEta δSTD 
1 N 24 1.90 1.80 -0.15 5.79 16.88 3.99 6.15 
2 D 52 0.20 0.00 0.17 7.26 2.16 -19.58 9.22 
3 V 84 0.00 0.00 0.20 4.88 2.30 -14.15 6.66 
4 W 129 -1.28 -0.19 0.24 -4.50 -5.21 -9.95 3.88 
5 P 189 0.07 -0.51 0.79 -0.90 15.29 -0.89 6.39 
6 P 248 0.70 0.16 0.49 10.59 -36.17 0.05 16.27 
7 P 285 -0.08 1.15 0.26 3.95 -0.01 1.83 1.55 
STD 0.95 0.82 0.29 5.07 17.61 9.03 5.63 
- STD: standard deviation 
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Table S4. The relative difference of the six degrees of freedom for each helix (x, y, z, θ, φ, η) of 
the x-ray structures of opsin (PDB ID: 3cap) compared to bovine rhodopsin (PDB ID: 
1u19).  
TM EtaRes δX δY δHPC δTheta δPhi δEta δSTD 
1 N 55 -0.55 -0.18 0.37 2.24 -4.64 -3.35 2.53 
2 D 83 0.08 0.00 -0.20 -2.12 -1.87 8.73 4.02 
3 A 117 0.00 0.00 -0.49 -0.63 -9.43 -26.02 10.43 
4 W 161 1.50 1.06 0.50 -1.03 -9.62 -14.42 6.70 
5 P 215 -1.18 3.25 0.16 0.10 -21.94 -4.54 9.13 
6 P 267 0.44 3.43 -0.02 3.61 39.84 -28.57 21.77 
7 P 303 -0.01 0.75 0.09 3.01 -11.19 0.24 5.03 
STD 0.83 1.54 0.34 2.21 19.79 13.85 6.42 
- STD: standard deviation 
 9 
Table S5. Top 10 predicted structures of human adenosine A1 and A2B receptors from the 
CombiHelix analysis of the (7)7 = 823,000 BiHelix packing geometries within ± 45 ° 
angle range by 15 ° increments. All 1,000 predicted structures from CombiHelix were 
selected for neutralization by their charge total energy score (ChargeTot: kcal/mol). The 
final 100 predicted structures are ordered by neutral total energy (NeutTot: kcal/mol). 
The case with η = 0 ° for all 7 helices (same as in the experimental antagonist bound 
A2AR structure) is shown in grey shading.  
A1           
H1 H2 H3 H4 H5 H6 H7 ChargeIH ChargeTot NeutIH NeuTot W6.48 χ1 
0 0 0 0 0 0 0 -360.2 465.1 -325.4 327.5 -67.8 
0 0 0 15 0 0 0 -340.5 467.0 -319.9 329.7 -67.8 
0 0 15 0 0 0 0 -361.5 445.4 -330.8 335.6 -67.6 
0 0 15 -30 0 0 0 -365.9 428.5 -320.6 340.0 -67.3 
0 0 15 -15 0 0 0 -350.5 457.3 -321.2 351.6 -67.6 
0 0 0 0 15 45 15 -313.4 508.2 -296.5 355.4 171.6 
0 0 0 0 15 15 0 -320.2 500.5 -301.9 359.2 153.5 
0 0 0 0 -15 0 0 -378.1 496.4 -331.4 359.8 -67.5 
0 0 15 15 0 0 0 -335.1 465.3 -317.8 360.6 -67.7 
0 0 15 0 0 15 0 -341.8 486.3 -319.0 363.6 -175.0 
A2B           
H1 H2 H3 H4 H5 H6 H7 ChargeIH ChargeTot NeutIH NeuTot W6.48 χ1 
0 0 0 0 0 0 0 -410.4 78.6 -372.2 -24.2 -78.9 
0 0 0 15 0 0 0 -384.5 99.0 -360.5 -5.3 -79.0 
0 0 0 0 15 0 0 -390.1 128.0 -360.2 -4.3 -78.9 
0 0 0 15 15 0 0 -360.5 142.7 -343.1 7.5 -79.0 
0 0 0 0 15 15 0 -391.3 128.4 -358.6 11.0 -144.8 
-15 0 0 0 0 0 0 -402.7 111.7 -357.6 14.3 -78.9 
0 0 0 0 -15 0 0 -392.7 153.3 -373.0 14.8 -79.1 
0 0 0 15 15 15 0 -359.0 138.8 -335.3 18.2 -144.8 
0 0 0 15 -15 0 0 -382.3 143.6 -367.6 18.5 -79.1 
-15 0 0 0 15 0 0 -388.7 142.6 -349.2 23.9 -78.9 
- ChargeIH (Charge interhelical energy), ChargeTot (Charge total energy), NeutIH (Neutral 
interhelical energy), NeutTot (Neutral total energy) 
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Table S6. Analysis of dominant interactions among the 20 most stable predicted structures of 
human A3 adenosine receptor (from the SuperBiHelix/ CombiHelix analysis in Table 2). 
The predicted structures are ordered by neutral total energy (NeutTot: kcal/mol). 
# 

















1 4.2 6.7 8.1 3.5 2.3 2.9 2.7 2.8 
2 3.7 5.4 7.9 3.2 2.5 2.9 2.7 2.8 
3 11.2 4.1 7.9 3.4 3.2 2.9 2.7 2.7 
4 3.7 5.4 8.5 3.2 2.5 2.7 4.0 2.8 
5 3.7 5.4 7.9 3.4 3.1 2.9 2.7 3.0 
6 3.8 6.3 8.2 3.2 4.4 3.8 4.9 3.1 
7 4.1 7.1 7.9 3.4 3.1 2.9 2.7 3.0 
8 10.1 6.7 5.7 4.7 2.5 4.8 2.8 2.8 
9 3.7 5.4 7.9 3.2 2.5 2.9 3.2 2.8 
10 4.2 7.3 7.9 3.4 3.1 2.9 2.7 3.0 
11 3.7 5.4 8.2 3.2 4.0 2.9 2.7 3.2 
12 9.6 4.6 5.7 4.7 2.5 4.8 2.8 2.8 
13 11.8 4.4 14.2 3.4 3.1 2.7 4.0 2.9 
14 3.7 5.4 7.9 3.4 5.2 2.9 2.7 3.5 
15 3.8 4.5 7.9 3.2 2.3 4.6 4.9 2.8 
16 3.7 5.4 4.9 5.0 3.4 5.4 3.1 2.8 
17 4.2 7.3 7.9 3.4 3.1 2.7 4.0 2.9 
18 4.2 7.3 7.9 3.4 3.1 3.0 4.5 2.9 
19 11.9 3.3 7.9 3.4 3.2 2.9 2.7 2.7 
20 3.7 5.4 8.0 3.4 4.5 5.4 3.9 2.8 
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Table S7. The χ1 angle of three toggle switch residues, W2436.48, Y2827.53, and R1083.50, of top 
20 predicted structures of human A3 adenosine receptor (from the SuperBiHelix/ 
CombiHelix analysis). All A3 agonists stabilize the 15th lowest conformation in orange 
shade, while the A3 antagonists stabilize the 2nd lowest conformation in yellow shade. 
# 
Torsion χ1 (apo-protein) Torsion χ1 (Agonist) Torsion χ1 (Antagonist) 
W243 Y282 R108 W243 Y282 R108 W243 Y282 R108 
1 -85.5 -64.9 -73.6 -174.9 -66.1 -73.4 -80.3 -66.0 -73.2 
2 -75.8 -65.0 -73.4 -164.5 -68.5 -71.8 -80.2 -68.5 -71.8 
3 -85.3 -57.7 -167.7 -70.9 -56.8 -173.9 -79.2 -56.8 -173.9 
4 -75.6 -72.3 -73.5 -174.9 -75.0 -72.7 -80.3 -74.9 -72.8 
5 -85.3 -51.4 -167.5 -69.4 -51.5 -172.8 -80.1 -51.5 -172.7 
6 -85.4 -173.9 -73.7 -170.9 -174.1 -75.2 -79.6 -174.1 -75.2 
7 -85.4 -65.0 -167.6 -70.9 -66.4 -172.2 -79.0 -66.5 -172.1 
8 -85.4 -64.7 -73.6 -164.0 -67.3 -71.6 -79.2 -67.3 -71.9 
9 -75.6 -71.1 -73.4 154.7 -72.6 -71.6 -84.8 -72.6 -71.6 
10 -85.5 -64.9 -167.6 -70.6 -66.5 -172.6 -79.1 -66.5 -172.6 
11 -85.2 -65.0 -73.9 -171.2 -68.4 -75.0 -80.8 -68.4 -75.0 
12 -85.3 -64.7 -73.6 -163.8 -67.4 -70.8 -79.5 -67.4 -70.8 
13 -85.6 -72.3 -67.7 -69.5 -75.1 -70.6 -80.9 -75.0 -70.6 
14 -85.3 -59.9 -167.5 -165.8 -60.0 -172.9 -80.2 -59.9 -173.0 
15 -75.8 -67.9 -73.4 154.4 -64.2 -73.2 -80.1 -64.2 -73.2 
16 -85.5 -60.8 -169.4 -171.0 -63.2 -169.4 -79.3 -63.3 -169.4 
17 -85.6 -72.2 -167.6 -69.2 -75.1 -172.5 -81.2 -75.1 -172.6 
18 -75.6 -79.8 -167.6 -69.4 -81.2 -172.6 -95.8 -81.2 -172.7 
19 -85.3 -60.6 -167.8 -69.3 -61.2 -173.3 -80.1 -61.1 -173.3 
20 -75.5 -51.4 -74.0 -171.3 -53.9 -75.8 -95.6 -53.9 -75.9 
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Table S8. DarwinDock results for the final top 25 poses for adenosine bound to lowest predicted 
structure of adenosine A3 receptor (AA3R). Predicted structures are ordered by the 
average ranking (Avg Rnk) of total (Tot) and unified cavity (Ucav) energies (kcal/mol). 
The lowest energy from each energy scoring is underlined. The predicted most stable 
adenosine/ AA3R complex based on unified cavity energy is underlined.  
Cluster # Avg Rnk Tot UCav 
c1276 3.5 -903.76 -36.64 
c17285 6.0 -892.47 -33.48 
c6058 6.0 -889.82 -38.43 
c17748 6.5 -900.41 -30.29 
c17395 7.0 -892.24 -32.00 
c24528 7.0 -905.33 -28.38 
c350 8.5 -893.19 -29.65 
c34565 9.0 -874.32 -35.20 
c16055 11.5 -891.79 -26.72 
c513 13.5 -905.24 -18.49 
c38371 13.5 -883.52 -26.69 
c3362 13.5 -870.15 -29.74 
c9913 13.5 -906.19 -1.77 
c37036 14.0 -888.92 -25.59 
c37853 14.5 -904.49 -12.42 
c16239 14.5 -859.81 -31.81 
c30401 15.5 -874.49 -24.71 
c18478 16.5 -857.07 -29.66 
c5512 17.5 -871.10 -24.59 
c32005 18.0 -873.90 -23.85 
c23634 18.5 -831.86 -29.51 
c31371 20.0 -849.71 -26.34 
c13623 20.0 -870.92 -21.55 
c12475 20.5 -862.89 -24.03 
c4971 21.0 -864.81 -23.85 
 
- Tot: total energy of the neutral complex, UCav: non-bonding cavity E of unified cavity 
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Table S9. DarwinDock results for the total 125 poses for Cl-IB-MECA. Total 125 poses from 25 
poses of five different ligand conformations are re-ordered by the average ranking (Avg 
Rnk) of total (Tot) and unified cavity (Ucav) energies (kcal/mol). The conformation 
number is from the energy order of the conformational search. The predicted most stable 
complex based on unified cavity energy is underlined.  
Conf # Cluster # Avg Rnk Tot UCav 
4 c2202 2.5 -534.82 -44.94 
2 c18650 10.5 -531.52 -41.01 
4 c420 11.5 -526.01 -43.26 
4 c12301 13.5 -533.55 -39.80 
4 c17790 15.5 -519.37 -44.40 
4 c8959 15.5 -532.12 -39.17 
2 c17930 17.5 -516.05 -50.33 
4 c7005 19.0 -519.33 -42.01 
3 c11193 20.5 -514.72 -44.84 
4 c4734 21.0 -530.98 -38.47 
4 c217 21.0 -540.71 -37.82 
3 c12951 21.5 -530.13 -38.55 
4 c13791 22.5 -514.54 -44.66 
2 c5829 26.0 -513.95 -42.74 
3 c935 26.0 -520.50 -39.00 
4 c10278 28.0 -517.64 -39.20 
4 c19180 28.0 -531.03 -36.88 
2 c5220 29.0 -525.70 -37.99 
4 c16175 29.5 -514.03 -40.65 
4 c12851 29.5 -525.80 -37.73 
4 c10462 31.0 -512.93 -40.48 
2 c14688 31.0 -530.78 -36.24 
4 c2927 31.5 -509.64 -42.89 
2 c16706 32.5 -511.11 -41.01 
4 c350 35.5 -515.39 -38.31 
2 c5760 36.5 -510.35 -39.95 
1 c1431 37.0 -508.04 -42.46 
2 c3889 37.0 -508.55 -41.37 
4 c1906 37.5 -525.33 -35.97 
4 c10605 39.0 -527.00 -35.38 
2 c3297 40.5 -508.46 -40.06 
1 c14552 41.5 -529.60 -34.04 
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4 c9525 42.0 -511.31 -38.11 
4 c13377 42.0 -522.48 -35.49 
1 c11696 42.5 -506.61 -40.74 
5 c5835 43.0 -509.58 -38.89 
2 c8325 44.5 -507.33 -39.57 
2 c2122 45.0 -522.26 -34.59 
1 c16495 45.5 -511.14 -37.70 
2 c1139 46.5 -526.26 -33.45 
4 c12995 48.0 -508.57 -38.22 
2 c13438 49.0 -515.01 -35.51 
4 c17812 49.0 -516.98 -35.30 
4 c15333 50.0 -514.63 -35.53 
3 c3208 51.5 -508.85 -37.18 
5 c8685 53.5 -501.59 -39.98 
5 c6114 53.5 -505.29 -38.36 
1 c12072 54.5 -508.40 -37.18 
2 c17328 56.5 -491.66 -43.15 
3 c11882 57.5 -508.62 -35.97 
2 c12559 58.5 -520.35 -31.12 
5 c8874 59.0 -506.87 -36.28 
4 c1722 59.5 -542.29 -22.91 
1 c12464 62.0 -518.53 -30.54 
2 c4389 62.5 -510.22 -33.84 
1 c8984 63.0 -518.19 -30.20 
4 c19512 63.0 -526.11 -26.25 
1 c10102 63.5 -503.23 -36.99 
1 c8087 64.0 -515.57 -30.78 
5 c19231 64.5 -482.81 -41.75 
3 c320 64.5 -493.10 -39.05 
1 c4647 64.5 -534.71 21.31 
2 c16815 65.5 -509.57 -33.69 
1 c18300 66.5 -492.14 -38.97 
1 c13348 67.5 -511.76 -31.72 
1 c18303 67.5 -527.68 -17.14 
1 c3142 68.0 -496.43 -37.70 
2 c6395 69.5 -488.05 -39.06 
3 c2304 69.5 -512.15 -30.71 
3 c4875 70.5 -524.64 -22.21 
5 c12150 73.5 -504.85 -33.77 
3 c13231 74.0 -503.25 -34.24 
3 c16803 74.0 -506.28 -33.46 
1 c18389 74.0 -517.88 -23.05 
5 c17222 74.5 -494.38 -36.56 
 15 
3 c10693 76.0 -481.18 -38.60 
1 c5497 76.5 -485.68 -38.07 
1 c18795 76.5 -503.38 -33.66 
3 c5519 77.0 -491.90 -36.64 
3 c5448 77.0 -517.96 3.88 
1 c16262 78.0 -492.43 -36.22 
2 c9500 78.0 -511.05 -27.65 
5 c14944 78.5 -504.47 -32.94 
1 c17888 79.0 -506.47 -31.76 
3 c10631 79.5 -494.37 -35.61 
1 c3940 80.0 -511.20 -25.56 
2 c3412 80.0 -514.65 -21.71 
2 c11833 80.5 -502.14 -33.34 
5 c15767 80.5 -504.42 -32.5 
5 c4877 81.5 -490.27 -36.15 
5 c1711 82.5 -491.58 -35.71 
5 c7813 84.0 -474.01 -37.43 
1 c9434 84.0 -509.81 -24.99 
3 c13553 84.5 -488.59 -35.76 
1 c19787 84.5 -506.77 -29.41 
5 c1782 85.0 -501.74 -32.51 
5 c4439 86.5 -494.51 -33.56 
3 c2145 86.5 -499.22 -32.69 
1 c1295 87.5 -494.95 -33.25 
3 c9183 89.0 -505.31 -27.49 
2 c17292 89.0 -507.95 -25.14 
5 c9381 89.5 -499.38 -31.61 
2 c7578 90.0 -502.71 -29.69 
5 c11766 90.5 -482.58 -35.47 
2 c4709 91.0 -493.58 -33.14 
5 c10280 91.0 -494.77 -32.26 
5 c5009 92.5 -481.94 -35.1 
2 c7547 92.5 -494.50 -32.11 
1 c12102 92.5 -502.08 -29.26 
3 c4521 93.0 -499.01 -30.57 
5 c9278 95.0 -480.14 -34.51 
5 c11301 96.5 -504.18 -23.41 
5 c3087 97.5 -467.51 -34.09 
3 c229 98.5 -496.43 -28.70 
3 c16808 99.5 -496.82 -27.08 
3 c17230 101.5 -500.99 -24.98 
3 c6702 102.0 -501.80 -22.74 
3 c5069 103.5 -501.99 -0.20 
 16 
1 c12935 104.0 -488.87 -29.76 
5 c8641 105.5 -488.6 -29.66 
5 c17960 107.0 -477.62 -31.2 
3 c14787 108.5 -491.32 -26.45 
3 c3496 110.0 -485.23 -28.07 
5 c13431 112.5 -485.99 -25.59 
5 c2005 114.0 -481.66 -26.52 









Figure S1. The hydropathy prediction from GEnSeMBLE method for human adenosine A3 receptor at 
window size 7 to 21. Initial transmembrane (TM) raw and capped helixes are shown with green 
and black line, respectively. The 7 TM regions from the homology helix are displayed in red 












Figure S2. (Left) In Bihelix sampling, each helix pair is to simultaneously rotate through 360° in 30° 
increments, leading to (12)7 = 35,000,000 configures.  (Right) The tilt (θ) of each axis from 
the z-axis, the azimuthal orientation (φ) of this tilt; and the rotation (η) of the helix about the 
helical axis for SuperBihelix. The x-axis is defined along the axis from the center point of 




















Figure S3. Predicted structure of agonist Cl-IB-MECA bound to adenosine A3 receptor (15-apo-A3) 
in purple and the opsin crystal structure (PDB ID: 3cap) in orange. This shows very similar 











Figure S4. Total energy, temperature and volume of (Left) antagonist LJ1251 and (Right) 
agonist Cl-IB-MECA bound human adenosine A3 receptor (hAA3R) through 10ns 







Figure S5. Important salt-bridges from (Top) R1083.50 of the D(E)RY motif with E2256.30 and 
from (Bottom) D1073.49 with R1264.41 of (Left) antagonist LJ1251 and (Right) agonist Cl-
IB-MECA bound human adenosine A3 receptor (hAA3R) through 10ns dynamics.   
